Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D03SLK
|
||||
| Former ID |
DNCL001610
|
||||
| Drug Name |
SAR292833
|
||||
| Indication | Pain [ICD9: 338, 356.0, 356.8,780; ICD10:G64, G90.0, R52, G89] | Phase 2 | [532424] | ||
| Company |
Sanofi-aventis; Glenmark Pharmaceuticals
|
||||
| Target and Pathway | |||||
| Target(s) | Transient receptor potential cation channel subfamily V member 3 | Target Info | Modulator | [532424] | |
| KEGG Pathway | Inflammatory mediator regulation of TRP channels | ||||
| Reactome | TRP channels | ||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.